₹344.20 per scrip on BSE, down 0.22 percent from the previous close. The Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients in early May.
The first batch of this oral drug, developed by the DRDO was released on May 17 by Defence Minister Rajnath Singh and then Health Minister Harsh Vardhan.
The Defence Ministry on May 8 had said that the clinical trials of 2-DG showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
The drug comes in powder form in sachet and is taken orally by dissolving it in water.Never miss a story! Stay connected and informed with Mint.